Ikeda T, Ogawa S, Kitazono T, Nakagawara J, et al. Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS. PLoS One 2021;16:e0251325.
PMID: 34115769